RUXOLITINIB for Neoplasm: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 56 adverse event reports in the FDA FAERS database where RUXOLITINIB was used for Neoplasm.
Most Reported Side Effects for RUXOLITINIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 12,492 | 18.3% | 1,527 | 1,769 |
| Death | 6,561 | 9.6% | 6,541 | 687 |
| Fatigue | 5,663 | 8.3% | 280 | 1,124 |
| Anaemia | 3,593 | 5.3% | 539 | 1,438 |
| Haemoglobin decreased | 3,297 | 4.8% | 456 | 1,306 |
| Platelet count decreased | 3,028 | 4.4% | 540 | 1,198 |
| Diarrhoea | 2,531 | 3.7% | 193 | 827 |
| Asthenia | 2,529 | 3.7% | 305 | 949 |
| Dizziness | 2,398 | 3.5% | 102 | 587 |
| Pneumonia | 2,343 | 3.4% | 643 | 1,726 |
| Headache | 2,271 | 3.3% | 97 | 541 |
| Product availability issue | 2,142 | 3.1% | 20 | 188 |
| Product dose omission issue | 2,130 | 3.1% | 41 | 281 |
| Dyspnoea | 2,042 | 3.0% | 258 | 886 |
| Splenomegaly | 1,995 | 2.9% | 292 | 686 |